12 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
and guidance beginning as early as Phase 1 and an organizational commitment to expedite the development and review of the product, including … , in exchange for a commitment that we vacate the facility by mid-November 2023, payment of one quarter of the November 2023 Base Rent, as defined
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
intensive FDA interaction and guidance beginning as early as Phase 1 and an organizational commitment to expedite the development and review … , on November 6, 2023, in exchange for a commitment that we vacate the facility by mid-November 2023, payment of one quarter of the November 2023 Base Rent
8-K
EX-2.1
SQZB
SQZ Biotechnologies Co
22 Dec 23
Entry into a Material Definitive Agreement
5:18pm
characteristics of a test article.
“Liability” or “Liabilities” means any liability, Tax, penalty, assessment, fine, claim, fee, commitment, debt, claim
8-K
EX-99.1
SQZB
SQZ Biotechnologies Co
6 Sep 22
SQZ Biotechnologies Announces Leadership Transition
4:33pm
a smooth transition of leadership and provide technical expertise as needed.
“I am deeply grateful for Howard’s commitment to SQZ over the past seven
S-1/A
EX-3.4
gftsvkcgzrjj0tsfdxzz
26 Oct 20
IPO registration (amended)
6:33am
S-1/A
EX-3.1
1xruc9yd
26 Oct 20
IPO registration (amended)
6:33am
S-1
EX-10.7
tv9xl32t qsk10osg
9 Oct 20
IPO registration
4:59pm
S-1
EX-3.1
zm58su 036f8
9 Oct 20
IPO registration
4:59pm
DRS/A
EX-10.7
yyye7x2
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
EX-3.1
407cl8caikt933condgc
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next